共 50 条
- [1] EFFICACY OF THE COMBINATION OF BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIAHAEMATOLOGICA, 2014, 99 : 591 - 591Zagoskina, T.Zotina, E.Ovsepyan, V.Shardakov, V.
- [2] Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaHEMASPHERE, 2018, 2 (03):Coutre, Steven E.Flinn, Ian W.de Vos, SvenBarrientos, Jacqueline C.Schreeder, Marshall T.Wagner-Johnson, Nina D.Sharman, Jeff P.Boyd, Thomas E.Fowler, NathanDreiling, LyndahKim, YeonheeMitra, SiddharthaRai, KantiLeonard, John P.Furman, Richard R.
- [3] Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemiaLEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1468 - 1474Weide, RudolfMergenthaler, UlrikeFriesenhahn, VeraKleboth, KristinaHeymanns, JochenThomalla, JoergKoeppler, Hubert
- [4] Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study GroupJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3559 - 3566Fischer, KirstenCramer, PaulaBusch, RaymondeStilgenbauer, StephanBahlo, JasminSchweighofer, Carmen D.Boettcher, SebastianStaib, PeterKiehl, MichaelEckart, Michael J.Kranz, GabrieleGoede, ValentinElter, ThomasBuehler, AndreasWinkler, DirkKneba, MichaelDoehner, HartmutEichhorst, Barbara F.Hallek, MichaelWendtner, Clemens-Martin
- [5] RITUXIMAB PLUS BENDAMUSTINE IN ELDERLY PATIENTS AFFECTED BY RELAPSED OR REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)HAEMATOLOGICA, 2014, 99 : 591 - 591Lucania, A.Villa, M. R.Izzo, G. NitratoImprota, S.Mastrullo, L.
- [6] Combination of bendamustine and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia: Experience of single center in RussiaEUROPEAN JOURNAL OF CANCER, 2013, 49 : S853 - S853Semochkin, S.Ivanova, V. L.Lukina, A. I.Mukha, L. A.Arshanskaya, E. G.Lazarev, I. E.Kulikova, S. S.Pochtar, M. E.Huazheva, N. K.Markaryan, V. G.
- [7] Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic LeukemiaBLOOD, 2014, 124 (21)Gladstone, DouglasAndre, MarcJan ZauchaAssouline, SaritBellam, NareshCascavilla, NicoleJourdan, EricPanwalkar, AmitPatti, CaterinaSchulte, ClemensZaja, FrancescoGoswami, TrishnaElgeioushi, NairouzStreicher, KatieBao, HaifengSpaner, David
- [8] Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaNEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12): : 1107 - 1120Seymour, J. F.Kipps, T. J.Eichhorst, B.Hillmen, P.D'Rozario, J.Assouline, S.Owen, C.Gerecitano, J.Robak, T.De la Serna, J.Jaeger, U.Cartron, G.Montillo, M.Humerickhouse, R.Punnoose, E. A.Li, Y.Boyer, M.Humphrey, K.Mobasher, M.Kater, A. P.
- [10] Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemiaHAEMATOLOGICA, 2019, 104 (10) : 2053 - 2060Steurer, MichaelMontillo, MarcoScarfo, LydiaMauro, Francesca R.Andel, JohannesWildner, SophieTrentin, LivioJanssens, AnnBurgstaller, SonjaFroemming, AnnaDuemmler, ThomasRiecke, KaiBaumann, MatthiasBeyer, DianaVauleon, StephanieGhia, PaoloFoa, RobinCaligaris-Cappio, FedericoGobbi, Marco